[1] |
HUANG Haozhe, CHEN Hong, ZHENG Dezhong, CHEN Chao, WANG Ying, XU Lichao, WANG Yaohui, HE Xinhong, YANG Yuanyuan, LI Wentao.
A CT-based radiomics nomogram for predicting local tumor progression of colorectal cancer lung metastases treated with radiofrequency ablation
[J]. China Oncology, 2024, 34(9): 857-872.
|
[2] |
CHEN Xun, ZHENG Zhenxia, RUAN Xueru.
Effects of TMCO1 on proliferation and migration of cervical cancer cells
[J]. China Oncology, 2024, 34(6): 571-580.
|
[3] |
FENG Zheng, GUO Qinhao, ZHU Jun, WU Xiaohua, WEN Hao.
Progress in treatment of gynecological cancer in 2023
[J]. China Oncology, 2024, 34(4): 340-360.
|
[4] |
SHEN Jie, FENG Xiaoshuang, WEN Hao, ZHOU Changming, MO Miao, WANG Zezhou, YUAN Jing, WU Xiaohua, ZHENG Ying.
Metastasis patterns and survival analysis of 572 patients with metastatic cervical cancer: a hospital-based real world study
[J]. China Oncology, 2024, 34(4): 361-367.
|
[5] |
MA Fenghua, JIANG Anqi, CHEN Yiqing, XU Congjian, KANG Yu.
Magnetic resonance imaging for distinguishing gastric-type endocervical adenocarcinoma from lobular endocervical glandular hyperplasia
[J]. China Oncology, 2024, 34(4): 380-388.
|
[6] |
LIU Qi, CHANG Cai, LI Jiawei.
Research progress on the correlation between imaging features and the molecular subtype, histopathology, clinical prognosis of ductal carcinoma in situ of the breast
[J]. China Oncology, 2024, 34(2): 201-209.
|
[7] |
WANG Yan, SU Yue, HU Tu, LIU Qiying, YAO Weiqiang, CHEN Yong, YAN Wangjun, ZHANG Zhen.
Retrospective analysis of short-term efficacy and safety of preoperative radiotherapy for 33 cases of locally high-risk soft tissue sarcoma
[J]. China Oncology, 2023, 33(7): 693-700.
|
[8] |
CHEN Ruchuan, LIU Wei, ZHOU Bingni, LIU Xiaohang, ZHOU Liangping.
The value of VI-RADS combined with tumor contact length in the detection of muscle-invasive bladder cancer
[J]. China Oncology, 2023, 33(3): 260-266.
|
[9] |
XIA Lingfang, ZHU Jun, WU Xiaohua.
The latest progress and prospect of gynecological tumor treatment at 2023 ESMO
[J]. China Oncology, 2023, 33(11): 969-980.
|
[10] |
GUO Qinhao, YU Min, WU Xiaohua.
Progress in diagnosis and treatment of gynecological tumors in 2022
[J]. China Oncology, 2023, 33(1): 14-24.
|
[11] |
PANG Yi, WU Chunxiao, GU Kai, BAO Pingping, WANG Chunfang, SHI Liang, GONG Yangming, XIANG Yongmei, DOU Jianming, WU Mengyin, FU Chen, SHI Yan.
Analysis of current status of cervical cancer incidence and mortality in Shanghai, 2016 and trends of 2002-2016
[J]. China Oncology, 2022, 32(6): 519-526.
|
[12] |
WANG Chuntao, GE Anxing, WU Hongyan, ZHANG Xueyan, YANG Sheng, YUAN Hongxiang, CHENG Yanping, FENG Yanlu, LU Xinyuan, LIANG Geyu.
The association between cervical lesions of different grades and lncRNA HOTTIP and H19 single nucleotide polymorphisms
[J]. China Oncology, 2022, 32(4): 324-334.
|
[13] |
FU Yuanyuan, HOU Runping, FU Xiaolong.
Research progress in predicting the risk of lymphatic or hematologic metastasis based on chest CT in early non-small cell lung cancer
[J]. China Oncology, 2022, 32(4): 343-350.
|
[14] |
ZHOU Bingni, LIU Xiaohang, GU Bingxin, ZHOU Liangping, GU Yajia.
The value of mpMRI combined with 99mTc-PSMA SPECT/CT in the detection of significant residual prostate cancer after neoadjuvant androgen deprivation therapy
[J]. China Oncology, 2022, 32(2): 134-141.
|
[15] |
FANG Yanhui , MA Caijuan , ZHANG Chunli , ZHAI Jiawei , ZHU Qiaoying , LIU Yin , ZHAO Xiwa .
miR-496 inhibits proliferation, migration and invasion of HeLa cell in cervical cancer via SFMBT1
[J]. China Oncology, 2021, 31(8): 697-703.
|